Jubilant Biosys Limited is attending the RAS-Targeted Drug Development Summit 2026 in Boston, MA from September 8-10.

Public source

Publisher name

Public post

Join Jubilant Biosys at the RAS-Targeted Drug Development Summit 2026. RAS remains one of the most important targets in oncology research, driving the need for innovativ…

Log in to read the full post

Company

Jubilant Biosys Limited

Your CRDMO partner in science

Industry
Pharmaceutical Manufacturing
Location
Noida, IN
Company size
1,001–5,000 employees

About Jubilant Biosys Limited

Jubilant Biosys is an integrated Contract Research, Development and Manufacturing Organization (CRDMO) providing drug discovery, development, and GMP manufacturing services to global pharmaceutical and biotech companies. Backed by 20+ years of experience, 1,300+ scientists, and operations across India and Europe, we support small molecule programs from discovery through commercial manufacturing, alongside discovery services for large molecules. Combining deep scientific expertise, advanced technologies, and a strong commitment to quality and sustainability, we help advance complex and time-sensitive programs with speed, precision, and reliability.

See more

Latest activity

7 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.